Molecular basis of common variable immunodeficiency

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 4, 2006, Pages 740-746

  Castigli, Emanuela ^a   Geha, Raif S ^a  

^a Children's Hospital   (United States)

Author keywords

B cells; Common variable immunodeficiency; IgA deficiency; TNF receptor; transmembrane activator and calcium modulator and cyclophilin ligand interactor mutations

Indexed keywords

CD19 ANTIGEN; CD20 ANTIBODY; CD40 LIGAND; CYCLOPHILIN; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ALLELE; ANTIBODY PRODUCING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT INHERITANCE; B LYMPHOCYTE; BACTERIAL INFECTION; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE TRANSMISSION; GENE LOCUS; GENE MUTATION; GENETIC DISORDER; HOMOZYGOSITY; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHENOTYPING; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMATIC HYPERMUTATION;

ANIMALS; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CELL DIFFERENTIATION; COMMON VARIABLE IMMUNODEFICIENCY; HUMANS; IGA DEFICIENCY; IMMUNOGLOBULIN CLASS SWITCHING; MEMBRANE PROTEINS; MICE; MUTATION; PLASMA CELLS; RECEPTORS, TUMOR NECROSIS FACTOR; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646066801     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.01.038     Document Type: Review

References (68)

1. Di Renzo M., Pasqui A.L., and Auteri A. Common variable immunodeficiency: a review. Clin Exp Med 3 (2004) 211-217
2. Kokron C.M., Errante P.R., Barros M.T., Baracho G.V., Camargo M.M., Kalil J., et al. Clinical and laboratory aspects of common variable immunodeficiency. An Acad Bras Cienc 76 (2004) 707-726
3. Schroeder Jr. H.W., Schroeder III H.W., and Sheikh S.M. The complex genetics of common variable immunodeficiency. J Investig Med 52 (2004) 90-103
4. Burrows P.D., and Cooper M.D. IgA deficiency. Adv Immunol 65 (1997) 245-276
5. Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol 21 (2001) 303-309
6. Weston S.A., Prasad M.L., Mullighan C.G., Chapel H., and Benson E.M. Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed?. Clin Exp Immunol 124 (2001) 465-469
7. Eastwood D., Gilmour K.C., Nistala K., Meaney C., Chapel H., Sherrell Z., et al. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin Exp Immunol 137 (2004) 584-588
8. Farrington M., Grosmaire L., Nonoyama S., Fischer S., Hollenbaugh D., Ledbetter J., et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A 91 (1994) 1099-1103
9. Grimbacher B., Hutloff A., Schlesier M., Glocker E., Warnatz K., Drager R., et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4 (2003) 261-268
10. Kralovicova J., Kusikova M., Buc M., Holomanova D., and Sakalova A. [Frequency of HLA-A, HLA-B and HLA-Cw antigens in the Slovak population]. Bratisl Lek Listy 101 (2000) 24-27
11. Islam K.B., Baskin B., Nilsson L., Hammarstrom L., Sideras P., and Smith C.I. Molecular analysis of IgA deficiency. Evidence for impaired switching to IgA. J Immunol 152 (1994) 1442-1452
12. Wang Z., Yunis D., Irigoyen M., Kitchens B., Bottaro A., Alt F.W., et al. Discordance between IgA switching at the DNA level and IgA expression at the mRNA level in IgA-deficient patients. Clin Immunol 91 (1999) 263-270
13. Asano T., Kaneko H., Terada T., Kasahara Y., Fukao T., Kasahara K., et al. Molecular analysis of B-cell differentiation in selective or partial IgA deficiency. Clin Exp Immunol 136 (2004) 284-290
14. Islam K.B., Nilsson L., Sideras P., Hammarstrom L., and Smith C.I. TGF-beta 1 induces germ-line transcripts of both IgA subclasses in human B lymphocytes. Int Immunol 3 (1991) 1099-1106
15. Bonhomme D., Hammarstrom L., Webster D., Chapel H., Hermine O., Le Deist F., et al. Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol 165 (2000) 4725-4730
16. Levy Y., Gupta N., Le Deist F., Garcia C., Fischer A., Weill J.C., et al. Defect in IgV gene somatic hypermutation in common variable immuno-deficiency syndrome. Proc Natl Acad Sci U S A 95 (1998) 13135-13140
17. Andersen P., Permin H., Andersen V., Schejbel L., Garred P., Svejgaard A., et al. Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency. Blood 105 (2005) 511-517
18. Geha R.S., Jabara H.H., and Brodeur S.R. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 3 (2003) 721-732
19. Nilsson L., Grant P., Larsson I., Pettersson S., and Sideras P. The human I alpha 1 region contains a TGF-beta 1 responsive enhancer and a putative recombination hotspot. Int Immunol 7 (1995) 1191-1204
20. Mao C, Stavnezer J. Differential regulation of mouse germline Ig gamma 1 and epsilon promoters by IL-4 and CD40. J Immunol 200;167:1522-34.
21. Lin Y., and Stavnezer J. Regulation of transcription of the germ-line Ig alpha constant region gene by an ATF element and by novel transforming growth factor-beta 1-responsive elements. J Immunol 149 (1992) 2914-2925
22. Park S.R., Lee J.H., and Kim P.H. Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes. Eur J Immunol 31 (2001) 1706-1715
23. Shi M.J., Park S.R., Kim P.H., and Stavnezer J. Roles of Ets proteins, NF-kappa B and nocodazole in regulating induction of transcription of mouse germline Ig alpha RNA by transforming growth factor-beta 1. Int Immunol 13 (2001) 733-746
24. Qiu G., and Stavnezer J. Overexpression of BSAP/Pax-5 inhibits switching to IgA and enhances switching to IgE in the I.29 mu B cell line. J Immunol 161 (1998) 2906-2918
25. Zelazowski P., Carrasco D., Rosas F.R., Moorman M.A., Bravo R., and Snapper C.M. B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline CH transcription and Ig class switching. J Immunol 159 (1997) 3133-3139
26. He B., Qiao X., and Cerutti A. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 173 (2004) 4479-4491
27. Castigli E., Wilson S.A., Scott S., Dedeoglu F., Xu S., Lam K.P., et al. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 201 (2005) 35-39
28. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3 (2002) 822-829
29. Mackay F., and Kalled S.L. TNF ligands and receptors in autoimmunity: an update. Curr Opin Immunol 14 (2002) 783-790
30. Mackay F., Schneider P., Rennert P., and Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 21 (2003) 231-264
31. Hendriks J., Planelles L., de Jong-Odding J., Hardenberg G., Pals S., Hahne M., et al. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 12 (2005) 637-648
32. Ingold K., Zumsteg A., Tardivel A., Huard B., Steiner Q., Cachero T., et al. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 201 (2005) 1375-1383
33. Lopez-Fraga M., Fernandez R., Albar J.P., and Hahne M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep 2 (2001) 945-951
34. Moreaux J., Cremer F.W., Reme T., Raab M., Mahtouk K., Kaukel P., et al. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106 (2005) 1021-1030
35. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293 (2001) 2111-2114
36. Gross J.A., Dillon S.R., Mudri S., Johnston J., Littau A., Roque R., et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity 15 (2001) 289-302
37. Castigli E., Scott S., Dedeoglu F., Bryce P., Jabara H., Bhan A.K., et al. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci U S A 101 (2004) 3903-3908
38. Sasaki Y., Casola S., Kutok J.L., Rajewsky K., and Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 173 (2004) 2245-2252
39. Shulga-Morskaya S., Dobles M., Walsh M.E., Ng L.G., MacKay F., Rao S.P., et al. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol 173 (2004) 2331-2341
40. Zhang X., Park C., Yoon S., Li L., Hsu Y., Ambrose C., et al. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int Immunol 17 (2005) 779-788
41. O'Connor B.P., Raman V.S., Erickson L.D., Cook W.J., Weaver L.K., Ahonen C., et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 199 (2004) 91-98
42. Yang M., Hase H., Legarda-Addison D., Varughese L., Seed B., and Ting A.T. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J Immunol 175 (2005) 2814-2824
43. von Bulow G.U., and Bram R.J. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278 (1997) 138-141
44. von Bulow G.U., van Deursen J.M., and Bram R.J. Regulation of the T-independent humoral response by TACI. Immunity 14 (2001) 573-582
45. Yan M., Wang H., Chan B., Roose-Girma M., Erickson S., Baker T., et al. Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2 (2001) 638-643
46. Seshasayee D., Valdez P., Yan M., Dixit V.M., Tumas D., and Grewal I.S. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18 (2003) 279-288
47. Bodmer J., Schneider P., and Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem Sci 27 (2002) 19-26
48. Banner D., D'Arcy A., Janes W., Gentz R., Schoenfeld H., Broger C.L., et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell Death Differ 73 (1993) 431-445
49. Hymowitz S., Patel D., Wallweber H., Runyon S., Yan M., Yin J., et al. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J Biol Chem 280 (2005) 7218-7227
50. Ni C., Oganesyan G., Welsh K., Zhu X., Reed J., Satterthwait A., et al. Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation. J Immunol 173 (2004) 7394-7400
51. Xia X.Z., Treanor J., Senaldi G., Khare S.D., Boone T., Kelley M., et al. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med 192 (2000) 137-143
52. Jabara H., Laouini D., Tsitsikov E., Mizoguchi E., Bhan A., Castigli E., et al. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 17 (2002) 265-276
53. Jabara H.H., and Geha R.S. Jun N-terminal kinase is essential for CD40-mediated IgE class switching in B cells. J Allergy Clin Immunol 115 (2005) 856-863
54. Ahonen C., Manning E., Erickson L., O'Connor B., Lind E., Pullen S., et al. The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. Nat Immunol 3 (2002) 451-456
55. von Bulow G.U., Russell H., Copeland N.G., Gilbert D.J., Jenkins N.A., and Bram R.J. Molecular cloning and functional characterization of murine transmembrane activator and CAML interactor (TACI) with chromosomal localization in human and mouse. Mamm Genome 11 (2000) 628-632
56. Castigli E., Wilson S., Garibyan L., Rachid R., Bonilla F., Schneider L., et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37 (2005) 829-834
57. Salzer U., Chapel H.M., Webster A.D., Pan-Hammarstrom Q., Schmitt-Graeff A., Schlesier M., et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37 (2005) 820-828
58. Reyes-Moreno C., Girouard J., Lapointe R., Darveau A., and Mourad W. CD40/CD40 homodimers are required for CD40-induced phosphatidylinositol 3-kinase-dependent expression of B7.2 by human B lymphocytes. J Biol Chem 279 (2004) 7799-7806
59. Siegel R., Frederiksen J., Zacharias D., Chan F., Johnson M., Lynch D., et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288 (2000) 2328-2329
60. Salzer U., and Grimbacher B. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency. Curr Opin Allergy Clin Immunol 5 (2005) 496-503
61. McAdam A.J., Greenwald R.J., Levin M.A., Chernova T., Malenkovich N., Ling V., et al. ICOS is critical for CD40-mediated antibody class switching. Nature 409 (2001) 102-105
62. Salzer U., Maul-Pavicic A., Cunningham-Rundles C., Urschel S., Belohradsky B.H., Litzman J., et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 113 (2004) 234-240
63. Tafuri A., Shahinian A., Bladt F., Yoshinaga S.K., Jordana M., Wakeham A., et al. ICOS is essential for effective T-helper-cell responses. Nature 409 (2001) 105-109
64. Warnatz K., Bossaller L., Salzer U., Skrabl-Baumgartner A., Schwinger W., van der Burg M., et al. Human ICOS-deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood (2005) Dec 29; E-pub ahead of print
65. Wong S.C., Oh E., Ng C.H., and Lam K.P. Impaired germinal center formation and recall T-cell-dependent immune responses in mice lacking the costimulatory ligand B7-H2. Blood 102 (2003) 1381-1388
66. Engel P., Zhou L.J., Ord D.C., Sato S., Koller B., and Tedder T.F. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3 (1995) 39-50
67. Rickert R.C., Rajewsky K., and Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376 (1995) 352-355
68. Rahman Z.S., Rao S.P., Kalled S.L., and Manser T. Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J Exp Med 198 (2003) 1157-1169